Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Cancer prevention research (Philadelphia, Pa.) - 1 Jan 2016

Kensler Thomas W, Spira Avrum, Garber Judy E, Szabo Eva, Lee J Jack, Dong Zigang, Dannenberg Andrew J, Hait William N, Blackburn Elizabeth, Davidson Nancy E, Foti Margaret, Lippman Scott M

Abstract excerpt

We have entered a transformative period in cancer prevention (including early detection). Remarkable progress in precision medicine and immune-oncology, driven by extraordinary recent advances in genome-wide sequencing, big-data analytics, blood-based technologies, and deep understanding of the tumor immune microenvironment (TME), has provided unprecedented possibilities to study the biology of premalignancy. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Precancerous Conditions
Share to Precision Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Cancer Vaccines

Share to Immune System

Share to Immunosuppressive Agents

Share to Randomized Controlled Trials as Topic

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 26744449
DOI: 10.1158/1940-6207.CAPR-15-0406
PMCID: PMC4955753

Genes

GEM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.PMID 26744449Read ↗

Leveraging premalignant biology for immune-based cancer preventionSemantic proximity Read ↗

Precancer Atlas to Drive Precision Prevention Trials.Semantic proximity Read ↗

Advances and challenges in cancer immunoprevention and immune interception.Semantic proximity Read ↗

Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future PerspectivesSemantic proximity Read ↗

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?Semantic proximity Read ↗

Translating Germline Cancer Risk into Precision Prevention.Semantic proximity Read ↗

The hallmarks of premalignant conditions: a molecular basis for cancer prevention.Semantic proximity Read ↗

The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signalling Pathways Is a Means to an EndSemantic proximity Read ↗

Moving pan-cancer studies from basic research toward the clinic.Semantic proximity Read ↗

Harnessing genomics for early cancer detection, risk stratification and prevention.Semantic proximity Read ↗

Genomic approaches to accelerate cancer interception.Semantic proximity Read ↗

Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical PerspectiveSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.